Skip to main content
Premium Trial:

Request an Annual Quote

CDC to Fund State Breast Cancer Genomics Efforts

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention plans to spend $2.7 million to support projects conducted by state and local governments to adopt evidence-based recommendations for genomic tests and other interventions for breast cancer.

The three-year program will provide $900,000 per year for three awards that will range between $200,000 and $300,000 each to support the projects, which are not to involve research activities.

The aim of the program is to adopt interventions in health practice that will help maximize the health benefits and minimize the potential harms of genomic tests for young women who are at high risk of developing breast cancer, the most commonly diagnosed cancer for women in the US.

To do that, these grants will fund state health departments to enhance their capabilities to promote the application of breast cancer genomics best practices through education, surveillance, and policy.

Applicants for the funding will propose to develop or enhance activities related to breast cancer genomics, such as increasing BRCA1 and BRCA2 counseling and testing; increasing coverage of appropriate BRCA1/2-related interventions; and developing educational programs to increase knowledge about breast cancer-related family history, risk assessment, and BRCA1/2 counseling for the public and healthcare providers.

CDC started the program because the Affordable Care Act of 2009 called for the agency to address breast cancer in young women and because it sees a need for enhancements in public health programs that use genomics.

According to the CDC, programs in policy and education are needed to help translate evidence-based genomic applications into clinical practice, and to increase the understanding of healthcare professionals and the public of the harms and benefits of breast cancer genomics.

Surveillance also is needed for breast cancer genomic applications and their outcomes, CDC said in its funding announcement.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.